MichaelAlexanderSpinnerMD

PubMed

• Emerging immunotherapies in the Hodgkin lymphoma armamentarium.
  Michael A Spinner, Ranjana H Advani
  Expert Opinion on Emerging Drugs. 2024-09-01
• 3 citations
  The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms.
  Vishesh Khanna, Rong Lu, Jyoti Kumar, Alfonso Molina, Henning Stehr
  Leukemia Research. 2024-01-01
• 3 citations
  Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
  Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova
  Blood Advances. 2023-12-12

Books/Book Chapters

• Williams Hematology 
  Chapter: 96: Hodgkin Lymphoma 
  Page 1683 - 1711Michael A Spinner, Eric Mou, Ranjana H. AdvaniMcGraw-Hill Education, New YorkEdition 10th,2021

Abstracts/Posters

• Correlating Clinical and Genomic Features with Ex Vivo Drug Sensitivity in Patients with Myelodysplastic Syndromes and Related Myeloid Neoplasms
  Michael A. Spinner, Steven A. Schaffert, Alexey Aleshin, Marianne Santaguida, Hiroomi Tada, Peter L. Greenberg, American Society of Hematology Annual Meeting, San Diego, CA, 12/7/2020
• CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions
  Victor Orellana-Noia, Daniel Reed, Jeremy Sen, Christian Barlow, Mary-Kate Malecek, Brad S. Kahl, Michael A. Spinner, Ranjana Advani, Timothy Voorhees, Anson Snow, Nat..., American Society of Hematology Annual Meeting, San Diego, CA, 12/6/2020
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Michael A Spinner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  Michael A Spinner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
  Michael A Spinner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  Michael A Spinner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Nonmyeloablative allogeneic transplantation using TLI-ATG conditioning for lymphoid and myeloid malignancies: mature follow up from a large single-institution cohort
  Spinner MA, Kennedy VE, Tamaresis JS, Lavori PW, Elder LV, Arai S, Johnston LJ, Meyer EH, Miklos DB, Muffly LS, Negrin RS, Rezvani AR, Shizuru JA, Weng W-K, Hoppe RT, ..., Blood, 12/3/2018
• Ex vivo drug response profiling defines novel drug sensitivity patterns for predicting clinical therapeutic responses in myeloid neoplasms
  Aleshin A, Santaguida M, Spinner MA, Sanders JN, Patterson SA, Gekas C, Schaffert S, Greenberg PL, Blood, 12/3/2018
• Consolidative CD8+ memory T-cell donor lymphocyte infusion augments donor chimerism with a low risk of GVHD following matched related donor hematopoietic cell transpla...
  Spinner MA, Muffly LS, Arai S, Johnston LJ, Meyer EH, Miklos DB, Negrin RS, Rezvani AR, Shizuru JA, Weng W-K, Strober S, Lowsky R, Blood, 12/7/2017
• Allogeneic transplants from HLA-mismatched unrelated donors using TLI-ATG conditioning retain a low risk of GVHD with at least as potent antitumor activity as with mat...
  Spinner MA, Fernandez-Vina M, Elder L, Arai S, Johnston L, Meyer E, Miklos D, Muffly L, Negrin RS, Shizuru J, Weng W, Laport G, Strober S, Lowsky R, Rezvani AR, Blood, 2016
• Large Granular Lymphocytes as Predictors of Morbidity and Early Mortality in GATA2 Deficiency
  Grossman J, Spinner MA, Sanchez LA, Hsu AP, Olivier KN, Zerbe CS, Calvo KR, Holland SM, Rosensweig SD, J Clin Immunol, 2014
• Hemophagocytic lymphohistiocytosis associated with NK cell dysfunction and disseminated herpesvirus infection in GATA2 deficiency
  Spinner MA, Odio C, Calvo KR, Hsu AP, Zerbe CS, Cuellar-Rodriguez J, Ker JP, Stoudenmire CJ, Fadare O, Ghosh A, Mace EM, Orange JS, Hickstein DD, Holland SM, Blood, 2014
• There's a fungus among us: bilateral cryptococcal pneumonia in an immunocompetent host
  Spinner MA, Greisman LA, American College of Physicians, San Francisco, CA, 2014
• Human Papillomavirus Infection in GATA2 Haploinsufficiency and Treatment with Interferon Alpha
  Zerbe CS, Cuellar-Rodriguez J, Sanchez LA, Spinner MA, Bagi P, Heller TT, Hickstein DD, Hsu AP, Mace EM, Stratton P, Orange JS, Holland SM, Infectious Diseases Society of America Annual Meeting, San Francisco, CA, 2013
• GATA2 Deficiency: Extended Clinical Phenotype in 57 Patients
  Spinner MA, Sanchez LA, Hsu AP, Calvo KR, Cuellar-Rodriguez J, Hickstein DD, Holland SM, J Clin Immunol, 2013
• Glucagon-like peptide-1 promotes beta cell proliferation and improves glycemic control in a murine model of neonatal diabetes
  Spinner MA, Papagiannis IG, Dai C, Powers AC, Endocrine Society Annual Meeting and Exposition, Boston, MA, 2011
• Join now to see all

Lectures

• A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Diffuse large B-cell lymphoma 
  Multidisciplinary Tumor Board, VA Palo Alto Health Care System - 8/22/2016
• GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity 
  Senior Lecture, Stanford Internal Medicine Residency Program - Palo Alto, CA - 2/29/2016
• GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity 
  Pediatric Hematology Grand Rounds, University of Michigan - Ann Arbor, MI - 10/23/2013
• GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity 
  NIH Medical Research Scholars Program Symposium - Bethesda, MD - 5/13/2013
• GATA2 deficiency: extended clinical phenotype in 57 patients 
  Clinical Immunology Society Annual Meeting, Plenary Session - Miami, FL - 4/26/2013
• GATA2 deficiency: extended clinical phenotype in 57 patients 
  Clinical Immunology Society Annual Meeting, Update in Primary Immunodeficiencies - Miami, FL - 4/25/2013
• Join now to see all